Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews
Cancer Medicine · 2024-02 · 13 (3)
DOI: 10.1002/cam4.6937 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 19.01.2024. Verfasst von Adam Todd und 14 weiteren Autor:innen. Beteiligte Einrichtung: Newcastle University, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programme Grants for Applied Research.
Abstract (Originalsprache)
Background
In oestrogen‐receptor positive breast cancer, daily oral adjuvant endocrine therapy (ET) for at least 5 years significantly reduces risks of recurrence and breast cancer‐specific mortality. However, many women are poorly adherent to ET. Development of effective adherence support requires comprehensive understanding of influences on adherence. We undertook an umbrella review to identify determinants of ET adherence.
Methods
We searched PubMed, Embase, CINAHL, PsycINFO, Cochrane and PROSPERO (inception to 08/2022) to identify systematic reviews on factors influencing ET adherence. Abstracted determinants were mapped to the World Health Organization's dimensions of adherence. Reviews were quality appraised and overlap assessed.
Results
Of 5732 citations screened, 17 reviews were eligible (9 quantitative primary studies; 4 qualitative primary studies; 4 qualitative or quantitative studies) including 215 primary papers. All five WHO dimensions influenced ET non‐adherence: The most consistently identified non‐adherence determinants were patient‐related factors (e.g. lower perceived ET necessity, more treatment concerns, perceptions of ET ‘cons’ vs. ‘pros’). Healthcare system/healthcare professional‐related factors (e.g. perceived lower quality health professional interaction/relationship) were also important and, to a somewhat lesser extent, socio‐economic factors (e.g. lower levels of social/economic/material support). Evidence was more mixed for medication‐related and condition‐related factors, but several may be relevant (e.g. experiencing side‐effects, cost). Potentially modifiable factors are more influential than non‐modifiable/fixed factors (e.g. patient characteristics).
Conclusions
The evidence‐base on ET adherence determinants is extensive. Future empirical studies should focus on less well‐researched areas and settings. The determinants themselves are numerous and complex in indicating that adherence support should be multifaceted, addressing multiple determinants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Newcastle University, Newcastle upon Tyne, UK.
- Royal College of Surgeons in Ireland, Dublin, Ireland.
- Oxford Brookes University, Oxford, UK.
- The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
- University College London, London, UK.
- Imperial College Healthcare NHS Trust, London, UK.
ORCID-Profile: Adam Todd
Förderung
- Programme Grants for Applied Research
Zitieren
APA
Todd, A., Waldron, C., McGeagh, L., Norris, R., Bolnykh, I., Stewart, S. J., Slodkowska-Barabasz, J., Moon, Z., Cahir, C., Thompson, S., Harmer, V., Wells, M., Watson, E., Sharp, L., & SWEET Research Team (2024). Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews. Cancer Medicine, 13(3). https://doi.org/10.1002/cam4.6937
Vancouver
Todd A, Waldron C, McGeagh L, Norris R, Bolnykh I, Stewart SJ, et al. Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews. Cancer Medicine. 2024;13(3). doi:10.1002/cam4.6937
BibTeX
@article{Todd2024,
author = {Todd, Adam and Waldron, Catherine and McGeagh, Lucy and Norris, Ruth and Bolnykh, Iakov and Stewart, Sarah Jane and Slodkowska-Barabasz, Joanna and Moon, Zoe and Cahir, Caitriona and Thompson, Sue and Harmer, Victoria and Wells, Mary and Watson, Eila and Sharp, Linda and SWEET Research Team, SWEET Research Team},
title = {Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {3},
doi = {10.1002/cam4.6937}
}
EUVIMED